ArticleJournal of experimental & clinical cancer research : CR2019

A subset of diffuse-type gastric cancer is susceptible to mTOR inhibitors and checkpoint inhibitors.

Hiroshi Fukamachi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.